Condition: Breast Cancer · Heart Failure · Sponsor: 4th Military Clinical Hospital with Polyclinic, Poland
The purpose of this study is to evaluate the effect of dapagliflozin on the incidence of cancer therapeutics-related cardiac dysfunction in patients with breast cancer receiving anthracycline treatment.
This description comes directly from the study's public registry record.
Bartosz Krakowiak, PhD, MD · +48 261 660 234 · bkrakowiak@4wsk.pl
Always discuss trial participation with your own doctor first.
| 4th Military Clinical Hospital with Polyclinic | Wroclaw, Lower Silesian Voivodeship, Poland | Recruiting |
| Lower Silesian Centre for Oncology, Lung Diseases and Hematology | Wroclaw, Lower Silesian Voivodeship, Poland | Recruiting |
| Military Medical Institute | Warsaw, Masovian Voivodeship, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06304857